The Magazine for Sleep Professionals
Tuesday, October 13, 2026
Mosanna Therapeutics, Inc., announced results from its Phase 1 MOSAIC study. MOS118 was safe and well tolerated across all doses, with no serious adverse events reported. These results support progression of the study into patients with OSA. “With these results we can now proceed to evaluate MOS118 in the patients it […]
Sleep problems are common in middle age, particularly among women in their 40s and 50s. In a new study published on September 1, 2026, in Journal of Wood Science, the researchers explored whether essential oils derived from Hinoki (Chamaecyparis obtusa), known as Japanese cypress, roots could help improve sleep quality. […]
Inspire Medical Systems, Inc. announced that the American Medical Association (AMA) CPT® Editorial Panel has approved the establishment of a new set of Current Procedural Terminology (CPT®) codes that accurately describe and include the Inspire V system. The new Category I codes are scheduled to take effect on January 1, […]
Vanda Pharmaceuticals Inc. announced positive topline results from its pivotal Phase III study of HETLIOZ® (tasimelteon) 20 mg in adults with Delayed Sleep-Wake Phase Disorder (DSWPD). Vanda intends to discuss these data with the U.S. Food and Drug Administration (FDA) and to submit a supplemental New Drug Application (sNDA) seeking […]
Lilly announced detailed results from TRIUMPH-2, a Phase 3 trial evaluating the efficacy and safety of retatrutide, an investigational, first-in-class GIP, GLP-1, and glucagon triple hormone receptor agonist, in adults with type 2 diabetes and obesity or overweight. At 80 weeks, all doses of retatrutide (4 mg, 9 mg, and […]
BMC Medical Co., Ltd. has recalled its Luna G3 APAP device (model LG3600) due to a firmware defect that can cause the machine to display an error message and shut down automatically, cutting off therapy delivery, the U.S. Food and Drug Administration announced. The FDA has classified the action as […]
Women with enlarged breast tissue, known medically as macromastia, may be more likely to experience chronic migraine, neck pain, certain spinal nerve disorders and obstructive sleep apnea, according to a new study by Wake Forest University School of Medicine researchers, published Tuesday in the journal Headache. The findings suggest enlarged […]
Aeroflow Sleep, a national durable medical equipment (DME) provider specializing in CPAP supplies, announced the results of a proprietary survey of 887 parents, which revealed a hidden health crisis happening due to parental sleep deprivation, with more than a quarter of respondents showcasing signs of undiagnosed sleep apnea. Parents are […]
BridgeBio Pharma, Inc., presented new exploratory analyses from PROPEL 3, the global Phase 3 pivotal study of oral infigratinib in children living with achondroplasia, showing directionally favorable trends beyond growth across medical complications associated with achondroplasia, including sleep apnea, otitis media, and body composition. These data were presented at the […]
Patients diagnosed with a temporomandibular disorder (TMD) are at increased risk for obstructive sleep apnea (OSA) compared to people without the disorder, according to a study published in the Journal of Oral and Maxillofacial Surgery (JOMS), the peer-reviewed official journal of the American Association of Oral and Maxillofacial Surgeons (AAOMS). TMD […]
